Intragraft blood dendritic cell antigen-1-positive myeloid dendritic cells increase during bk polyomavirus-associated nephropathy

Journal of the American Society of Nephrology

Volumn 27, Issue 8, 2016, Pages 2502-2510

  Yapici, Ünsal ^a   Kers, Jesper ^a   Slavujevic Letic, Ivana ^a   Stokman, Geurt ^a   Roelofs, Joris J T H ^a   Van Aalderen, Michiel C ^b   Groothoff, Jaap W ^c   De Boer, Onno J ^a   Van Der Pant, Karlijn A M I ^b   Claessen, Nike ^a   Hilbrands, Luuk B ^d   Bemelman, Frederike J ^b   Ten Berge, Ineke J M ^b   Florquin, Sandrine ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Renal Transplant Unit   (United States)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD1 ANTIGEN; CD1C PROTEIN, HUMAN; GLYCOPROTEIN;

ADULT; ARTICLE; BK VIRUS; BLOOD DENDRITIC CELL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; BONE MARROW CELL; COMPARATIVE STUDY; DENDRITIC CELL; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; POLYOMAVIRUS INFECTION; POSTOPERATIVE COMPLICATION; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION;

ADULT; ANTIGENS, CD1; BK VIRUS; CASE-CONTROL STUDIES; DENDRITIC CELLS; FEMALE; GLYCOPROTEINS; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYELOID CELLS; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS;

EID: 84989357509     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015040442     Document Type: Article

References (33)

1. Marcén R: Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs 69: 2227-2243, 2009
2. Ramos E, Drachenberg CB, Wali R, Hirsch HH: The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 87: 621-630, 2009
3. Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, Hariharan S: Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 71: 896-899, 2001
4. Latif S, Zaman F, Veeramachaneni R, Jones L, Uribe-Uribe N, Turbat-Herrera EA, Herrera GA: BK polyomavirus in renal transplants: Role of electron microscopy and immunostaining in detecting early infection. Ultrastruct Pathol 31: 199-207, 2007
5. Li X, SunQ, Chen J, Ji S,Wen J, ChengD, Liu Z: Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection. Clin Dev Immunol 2013: 412902, 2013
6. Mannon RB, Hoffmann SC, Kampen RL, Cheng OC, Kleiner DE, Ryschkewitsch C, Curfman B, Major E, Hale DA, Kirk AD: Molecular evaluationofBKpolyomavirus nephropathy. AmJ Transplant 5: 2883-2893, 2005
7. Rogers NM, Russ GR, Cooper J, Coates PT: Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejection. Nephrology (Carlton) 14: 118-122, 2009
8. Buettner M, Xu H, Böhme R, Seliger B, Jacobi J, Wiesener M, Benz K, Amann K: Predominance of TH2 cells and plasma cells in polyoma virus nephropathy:A role for humoral immunity?HumPathol 43: 1453-1462, 2012
9. Nickeleit V, Hirsch HH, Zeiler M, Gudat F, Prince O, Thiel G, Mihatsch MJ: BK-virus nephropathy in renal transplants-tubular necrosis, MHCclass II expression and rejection in a puzzling game. Nephrol Dial Transplant 15: 324-332, 2000
10. Menter T, Mayr M, Schaub S, Mihatsch MJ, Hirsch HH, Hopfer H: Pathology of resolving polyomavirus-associated nephropathy. Am J Transplant 13: 1474-1483, 2013
11. Masutani K, Shapiro R, Basu A, Tan H, Ninomiya T, Randhawa P: Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia. Transplantation 94: 43-49, 2012
12. Bracamonte E, Leca N, Smith KD, Nicosia RF, Nickeleit V, Kendrick E, Furmanczyk PS, Davis CL, Alpers CE, Kowalewska J: Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy. Am J Transplant 7: 1552-1560, 2007
13. Batal I, Zainah H, Stockhausen S, Basu A, Tan H, Shapiro R, Zeevi A, Girnita A, Randhawa P: The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy. Mod Pathol 22: 1468-1476, 2009
14. Rogers NM, Ferenbach DA, Isenberg JS, Thomson AW, Hughes J: Dendritic cells and macrophages in the kidney: A spectrum of good and evil. Nat Rev Nephrol 10: 625-643, 2014
15. Woltman AM, de Fijter JW, Zuidwijk K, Vlug AG, Bajema IM, van der Kooij SW, van Ham V, van Kooten C: Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 71: 1001-1008, 2007
16. Womer KL, Huang Y, Herren H, Dibadj K, Peng R, Murawski M, Shraybman R, Patton P, Clare-Salzler MJ, Kaplan B: Dendritic cell deficiency associatedwith development of BK viremia and nephropathy in renal transplant recipients. Transplantation 89: 115-123, 2010
17. MengelM, Reeve J, Bunnag S, EineckeG, Jhangri GS, Sis B, Famulski K, Guembes-Hidalgo L, Halloran PF: Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 9: 1859-1867, 2009
18. Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice: BK polyomavirus in solid organ transplantation. Am J Transplant 13[Suppl 4]: 179-188, 2013
19. Schaub S,Hirsch HH,DickenmannM, Steiger J,Mihatsch MJ,HopferH, Mayr M: Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant 10: 2615-2623, 2010
20. Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, Woodle ES, Khalili K, Koralnik IJ: Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 80: 3495-3505, 2006
21. Comoli P, Azzi A, Maccario R, Basso S, Botti G, Basile G, Fontana I, Labirio M, Cometa A, Poli F, Perfumo F, Locatelli F, Ginevri F: Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78: 1229-1232, 2004
22. Zuidwijk K, de Fijter JW, Mallat MJK, Eikmans M, van Groningen MC, Goemaere NN, Bajema IM, van Kooten C: Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome. Kidney Int 81: 64-75, 2012
23. Kemény E, Hirsch HH, Eller J, Dürmüller U, Hopfer H, Mihatsch MJ: Plasma cell infiltrates in polyomavirus nephropathy. Transpl Int 23: 397-406, 2010
24. Meehan SM, Kadambi PV, Manaligod JR,Williams JW, JosephsonMA, Javaid B: Polyoma virus infection of renal allografts: Relationships of the distribution of viral infection, tubulointerstitial inflammation, and fibrosis suggesting viral interstitial nephritis in untreated disease. Hum Pathol 36: 1256-1264, 2005
25. Rosenberg AS, Singer A: Cellular basis of skin allograft rejection: An in vivomodel of immune-mediated tissue destruction. Annu Rev Immunol 10: 333-358, 1992
26. vonWillebrand E, Pettersson E, Ahonen J, Häyry P: CMVinfection, class II antigen expression, and human kidney allograft rejection. Transplantation 42: 364-367, 1986
27. Ramaswami B, Popescu I, Macedo C, Luo C, Shapiro R, Metes D, Chalasani G, RandhawaPS: The polyomavirus BKlarge T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol 18: 815-824, 2011
28. Hirsch HH: Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2: 25-30, 2002
29. van der Loos CM: Multiple immunoenzyme staining: Methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 56: 313-328, 2008
30. Yapici Ü, Kers J, Bemelman FJ, Roelofs JJTH, Groothoff JW, van der Loos CM, van Donselaar-van der Pant KAMI, Idu MM, Claessen N, ten Berge IJM, Florquin S: Interleukin-17 positive cells accumulate in renal allografts during acute rejection and are independent predictors of worse graft outcome. Transpl Int 24: 1008-1017, 2011
31. Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MCR, David DSR, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, LiapisH, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee: Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14: 272-283, 2014
32. AdamB, Randhawa P, Chan S, Zeng G, Regele H, Kushner YB, Colvin RB, Reeve J, Mengel M: Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): Reproducibility of polyomavirus immunohistochemistry in kidney allografts. Am J Transplant 14: 2137-2147, 2014
33. Rubin DB: Multiple Imputation for Nonresponse in Surveys. Available at: http://doi. wiley. com/10. 1002/9780470316696. ch1. Accessed November 28, 2013